Waters Honours Singapore’s Bioprocessing Technology Institute (BTI) for Glycoscience Research

At a ceremony and symposium on 27 February, Waters Corporation welcomed into its Centers of Innovation Program the Bioprocessing Technology Institute (BTI), a research institute under Singapore’s Agency for Science, Technology and Research (A*STAR). BTI is the first research institute focused on glycobiology to participate in the Waters Centers of Innovation Program.

“I am delighted that BTI has been recognised by Waters for its expertise in glycomics. Through this collaboration, BTI will be able to advance cancer biomarker research and further cement Singapore’s position as a key player in biologics,” said Professor Lam Kong-Peng, Executive Director of BTI.

“This award also recognises the importance of the integrated research programmes that are fundamental to the success of BTI,” added Professor Lam.

“It’s truly a pleasure to have BTI participate in our COI Program,” said Dr Mike Harrington, Senior Vice President, Global Markets for Waters Corporation. “BTI’s research in glycobiology is world-class and we wish to help it realise the enormous potential of this very important area of science through the application of Waters analytical technologies and expertise.”

In 2016, Waters and BTI announced a collaboration to develop a glycoconjugate database and spectral library that would assist researchers using mass spectrometry in identifying glycans in their samples. As part of this collaboration, Waters is contributing scientific expertise and the use of a Waters® SYNAPT® G2-S High Definition Mass Spectrometry® System.

The glycoscience programme, headed by Professor Pauline Rudd and Dr Terry Nguyen-Khuong, Scientist of BTI, will further develop and apply state-of-the-art technology to advanced bioprocessing and biologic characterisation, development and production.